Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

Breast Health — Recognizing the high proportion of local women with dense breast tissue, Johnson County Hospital invested in ...

Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially doubling its U.S. manufacturing capacity and ...

The last time I wrote an article on ORIC Pharmaceuticals (NASDAQ:ORIC) it was with respect to a Seeking Alpha article ...

Beleaguered Belgian biotech Galapagos said yesterday that its CEO, Paul Stoffels, plans to retire upon the appointment of his ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

UnitedHealth reveals spending of $1.7 million on executive security following targeted violence concerns. Read more.

That means the future of Roivant is tied to the success, or otherwise, of Immunovant’s attempts to break into the FcRn market ...

The global pharmaceutical industry could generate about $1.2 trillion in sales in 2025, according to Statista, and projections call for 4.7% annual growth through 2029. The cancer treatment ...

Five face drug charges in separate cases New drugs charges have been lodged against Jaser James Bragg, who was arrested on ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

If Trump decides to launch strikes on Mexico's international drug cartels, the Roosevelt Reservation could be a key staging ...